What question did this study set out to answer?

To assess the efficacy of short-term resveratrol supplementation in reducing blood glucose and metabolic markers in patients with type 2 diabetes receiving standard antidiabetic treatment.

January 1, 2013Evidence-based Complementary and Alternative MedicineOpen Access

Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients

View Full Paper

Ask AI

Bookmark

Authors

AMAli MovahedBushehr University of Medical Sciences INIraj NabipourBiotechnology Research Center XLXavier Lieben LouisAgriculture and Agri-Food Canada

Discussion

Member takes

Implication

Randomized double-blind trial shows daily resveratrol improves glycemic control and lipid profiles in type 2 diabetes, suggesting potent antidiabetic benefits alongside standard therapy.

Key Points

To assess the efficacy of short-term resveratrol supplementation in reducing blood glucose and metabolic markers in patients with type 2 diabetes receiving standard antidiabetic treatment.
Randomized, double-blind, placebo-controlled parallel clinical trial conducted in 66 patients with type 2 diabetes.
Participants were randomly assigned to receive either oral resveratrol (1 g/day) or placebo for 45 days alongside standard therapy.
Metabolic parameters (fasting blood glucose, HbA1c, insulin, HOMA-IR, lipid profile, blood pressure) and safety markers of liver and kidney function were evaluated at baseline and day 45.
Resveratrol supplementation significantly reduced systolic blood pressure, fasting blood glucose, HbA1c, insulin, and insulin resistance compared to baseline levels.
High-density lipoprotein (HDL) levels increased significantly in the resveratrol arm, whereas the placebo group exhibited slight increases in fasting glucose and LDL cholesterol.
Liver and kidney function markers remained unchanged after 45 days in the intervention group.

Cite This Study

Movahed et al. (2013) studied this question.

synapsesocial.com/papers/6a7e221fb7d9fb789ca2a33b https://doi.org/10.1155/2013/851267

View Full Paper

Ask AI

Bookmark

Implication

Randomized double-blind trial shows daily resveratrol improves glycemic control and lipid profiles in type 2 diabetes, suggesting potent antidiabetic benefits alongside standard therapy.

Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients

Discussion

Member takes

Implication

Key Points

Cite This Study

Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider